Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 2/20 | 0.64 |
| ▸ | GNAI3 | P08754 | 7/20 | 0.56 |
| ▸ | GNAO1 | P09471 | 7/20 | 0.56 |
| ▸ | GNAI1 | P63096 | 7/20 | 0.56 |
| ▸ | S1PR5 | Q9H228 | 3/20 | 0.53 |
| ▸ | BCHE | P06276 | 5/20 | 0.53 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.52 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.52 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6216002 | 1.00 | KCNH2 (0.64) | KCNH2GNAI3GNAO1GNAI1S1PR5 | |
| SCHEMBL9492760 | 1.00 | KCNH2 (0.64) | KCNH2GNAI3GNAO1GNAI1S1PR5 | |
| SCHEMBL31549854 | 1.00 | KCNH2 (0.64) | KCNH2GNAI3GNAO1GNAI1S1PR5 | |
| SCHEMBL9493891 | 1.00 | KCNH2 (0.64) | KCNH2GNAI3GNAO1GNAI1S1PR5 | |
| SCHEMBL31549845 | 1.00 | KCNH2 (0.64) | KCNH2GNAI3GNAO1GNAI1S1PR5 | |
| SCHEMBL31549853 | 1.00 | KCNH2 (0.64) | KCNH2GNAI3GNAO1GNAI1S1PR5 | |
| SCHEMBL396677 | 0.98 | KCNH2 (0.61) | KCNH2GNAI3GNAO1GNAI1S1PR5 | |
| Hydrochloric Acid SCHEMBL6206412 | 0.96 | KCNH2 (0.60) | KCNH2GNAI3GNAO1GNAI1S1PR5 | |
| Sulfuric Acid SCHEMBL9493803 | 0.94 | KCNH2 (0.58) | KCNH2GNAI3GNAO1GNAI1S1PR5 | |
| SCHEMBL6944812 | 0.93 | KCNH2 (0.55) | KCNH2GNAI3GNAO1GNAI1S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025068428-A1 | N-HETEROCYCLIC COMPOUNDS AND THEIR USE AS SURFACTANTS | BASF SE (DE) | 2025-04-03 | — | — | WO | claimed |
| WO-2025068428-A1 | N-HETEROCYCLIC COMPOUNDS AND THEIR USE AS SURFACTANTS | BASF SE (DE) | 2025-04-03 | — | — | WO | disclosed |
| US-10954239-B2 | Imidazoquinoline amine derivatives, pharmaceutical compositions and therapeutic methods thereof | CANWELL BIOTECH LIMITED (CN) | 2021-03-23 | — | — | US | disclosed |
| US-20200407358-A1 | IMIDAZOQUINOLINE AMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS THEREOF | CANWELL BIOTECH LIMITED (HK) | 2020-12-31 | — | — | US | disclosed |
| WO-2020160054-A1 | IMIDAZOQUINOLINE AMINE DERIVATIVES, PHARMACEUTICAL COMPOSITION, USE THEREOF | CANWELL BIOTECH LIMITED (CN) | 2020-08-06 | — | — | WO | disclosed |
| US-5268472-A | Monopersulfate salt | AUSIMONT S.P.A. (IT) | 1993-12-07 | — | — | US | disclosed |
| EP-0300462-B1 | HETEROCYCLIC PEROXYCARBOXYLIC ACIDS | AUSIMONT S.p.A. (IT) | 1993-09-29 | — | — | EP | disclosed |
| EP-0340755-B1 | MONOPERSULFATES OF NITROGEN CONTAINING HETEROCYCLIC (POLY)PERCARBOXYLIC ACIDS | AUSIMONT S.p.A. (IT) | 1993-09-01 | — | — | EP | disclosed |
| US-5071584-A | Storage stable, heat resistant | AUSIMONT S.P.A. (IT) | 1991-12-10 | — | — | US | disclosed |
| EP-0340755-A1 | Monopersulfates of nitrogen containing heterocyclic (poly)percarboxylic acids | AUSIMONT S.p.A. (IT) | 1989-11-08 | — | — | EP | disclosed |
| EP-0300462-A2 | Heterocyclic peroxycarboxylic acids | AUSIMONT S.p.A. (IT) | 1989-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10954239-B2 | Imidazoquinoline amine derivatives, pharmaceutical compositions and therapeutic methods thereof | TLR8, TLR7, TLR1 | KCNH2 1458/4885GNAI3 174/4885GNAO1 418/4885 |
| US-20200407358-A1 | IMIDAZOQUINOLINE AMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS THEREOF | TLR8, TLR7, TLR1 | KCNH2 1458/4885GNAI3 174/4885GNAO1 418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.